Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study

References

• Zheng Y, Liu A, Wang ZJ, et al. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease. Brain. 2019;142(3):787–807. doi:10.1093/brain/awy35430668640
   PubMed Web of Science ®Google Scholar
• Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:1–18. doi:10.1216/RMJ-1977-7-4-775
   Web of Science ®Google Scholar
• Schooling CM, Freeman G, Cowling BJ. Mendelian randomization and estimation of treatment efficacy for chronic diseases. Am J Epidemiol. 2013;177(10):1128–1133. doi:10.1093/aje/kws34423585329
   PubMed Web of Science ®Google Scholar
• Hemani G, Bowden J, Smith GD. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):195–208. doi:10.1093/hmg/ddy163
   PubMed Web of Science ®Google Scholar
• Antuono PG, Jones JL, Wang Y, Li SJ. Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with 1 H-MRS at 0.5 T. Neurology. 2001;56(6):737–742. doi:10.1212/WNL.56.6.73711274307
   PubMed Web of Science ®Google Scholar
• Olabarria M, Noristani HN, Verkhratsky A, Rodríguez JJ. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer’s disease mouse model: mechanism for deficient glutamatergic transmission? Mol Neurodegener. 2011;6(1):1–9. doi:10.1186/1750-1326-6-5521211002
   PubMed Web of Science ®Google Scholar
• Chen J, Herrup K. Glutamine acts as a neuroprotectant against DNA damage, beta-amyloid and H 2o2-induced stress. PLoS One. 2012;7(3):e33177. doi:10.1371/journal.pone.003317722413000
   PubMed Web of Science ®Google Scholar
• Wang L, Maher TJ, Wurtman RJ. Oral L-glutamine increases GABA levels in striatal tissue and extracellular fluid. FASEB J. 2007;21(4):1227–1232. doi:10.1096/fj.06-7495com17218538
   PubMed Web of Science ®Google Scholar
• Kettunen J, Demirkan A, Wurtz P, et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun. 2016;7:1–9. doi:10.1038/ncomms11122
   Web of Science ®Google Scholar
• Lambert J-C, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45(12):1452–1458. doi:10.1038/ng.2802.Meta-analysis24162737
   PubMed Web of Science ®Google Scholar
• Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:1–29. doi:10.7554/eLife.34408
   Web of Science ®Google Scholar
• Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–665. doi:10.1002/gepi.2175824114802
   PubMed Web of Science ®Google Scholar
• Bowden J, Smith GD, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi:10.1093/ije/dyv08026050253
   PubMed Web of Science ®Google Scholar
• Johnson T Efficient calculation for multi-SNP genetic risk scores. American Society of Human Genetics Annual Meeting; 2012 San Francisco. doi:10.1038/ng.784.
   Google Scholar
• Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16(4):309–330. doi:10.1177/096228020607774317715159
   PubMed Web of Science ®Google Scholar
• Spiller W, Davies NM, Palmer TM. Software application profile: mrrobust — a tool for performing two-sample summary Mendelian randomization analyses. Int J Epidemiol. 2019;48(3):684–690. doi:10.1093/ije/dyy195
   Web of Science ®Google Scholar
• Bowden J, Smith GD, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–314. doi:10.1002/gepi.2196527061298
   PubMed Web of Science ®Google Scholar
• Hartwig FP, Davey Smith G. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;(July):1985–1998. doi:10.1093/ije/dyx10229040600
   PubMed Web of Science ®Google Scholar
• Zhao Q, Wang J, Hemani G, Bowden J, Small DS. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. arXiv. 2018
   Google Scholar
• Yarmolinsky J, Relton CL, Lophatananon A, et al. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: a Mendelian randomization analysis. PLoS Med. 2019;16(8):e1002893. doi:10.1371/journal.pmed.100289331390370
   PubMed Web of Science ®Google Scholar
• Hwang L, Lawlor DA, Freathy RM, Evans DM, Warrington NM. Using a two-sample Mendelian randomization design to investigate a possible causal effect of maternal lipid concentrations on offspring birth weight. Int J Epidemiol. 2019;005:1–11. doi:10.1093/ije/dyz160
   Web of Science ®Google Scholar
• Staley JR, Blackshaw J, Kamat MA, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016;32(20):3207–3209. doi:10.1093/bioinformatics/btw37327318201
   PubMed Web of Science ®Google Scholar
• Kamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations. Bioinformatics. 2019;(June):1–3. doi:10.1093/bioinformatics/btz469
   Web of Science ®Google Scholar
• Xiang J, Ennis SR, Abdelkarim GE, Fujisawa M, Kawai N, Keep RF. Glutamine transport at the blood-brain and blood-cerebrospinal fluid barriers. Neurochem Int. 2003;43(4–5):279–288. doi:10.1016/S0197-0186(03)00013-512742070
   PubMed Web of Science ®Google Scholar
• Richmond R, Wade K, Corbin L, et al. Investigating the role of insulin in increased adiposity: bi-directional Mendelian randomization study. bioRxiv. 2017:1–18. doi:10.1101/155739
   Google Scholar
• Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–98. doi:10.1093/hmg/ddu32825064373
   PubMed Web of Science ®Google Scholar
• Machiela MJ, Chanock SJ. LDassoc: an online tool for interactively exploring genome-wide association study results and prioritizing variants for functional investigation. Bioinformatics. 2018;34(5):887–889. doi:10.1093/bioinformatics/btx56128968746
   PubMed Web of Science ®Google Scholar
• Pierce BL, Burgess S. Efficient design for mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178(7):1177–1184. doi:10.1093/aje/kwt08423863760
   PubMed Web of Science ®Google Scholar
• Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740–752. doi:10.1093/ije/dyq15120813862
   PubMed Web of Science ®Google Scholar
• Brion MA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42:1497–1501. doi:10.1093/ije/dyt17924159078
   PubMed Web of Science ®Google Scholar
• Hemani G, Zheng J, Wade KH, et al. MR-base: a platform for systematic causal inference across the phenome using billions of genetic associations. bioRxiv. 2016. doi:10.1101/078972
   Google Scholar
• Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734–1739. doi:10.1093/ije/dyx03428398548
   PubMed Web of Science ®Google Scholar
• Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377–389. doi:10.1007/s10654-017-0255-x28527048
   PubMed Web of Science ®Google Scholar
• Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961–1974. doi:10.1093/ije/dyw22027616674
   PubMed Web of Science ®Google Scholar
• Kolesár M, Chetty R, Friedman J, Glaeser E, Imbens GW. Identification and inference with many invalid instruments. J Bus Econ Stat. 2015;33(4):474–484. doi:10.1080/07350015.2014.978175
   Web of Science ®Google Scholar
• van der Lee SJ, Teunissen CE, Pool R, et al. Circulating metabolites and general cognitive ability and dementia: evidence from 11 cohort studies. Alzheimer’s Dement. 2018;14(6):707–722. doi:10.1016/j.jalz.2017.11.01229316447
   PubMed Web of Science ®Google Scholar
• Madeira C, Vargas-Lopez C, Otávio Brandao C, et al. Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer’s disease and depression. Front Psychiatry. 2018;9:(NOV):1–8. doi:10.3389/fpsyt.2018.00561
   Web of Science ®Google Scholar
• Andersen JV, Christensen SK, Aldana BI, Nissen JD, Tanila H, Waagepetersen HS. Alterations in cerebral cortical glucose and glutamine metabolism precedes amyloid plaques in the APPswe/PSEN1dE9 mouse model of Alzheimer’s disease. Neurochem Res. 2017;42(6):1589–1598. doi:10.1007/s11064-016-2070-227686658
   PubMed Web of Science ®Google Scholar
• De Strooper B, Karran E. The cellular phase of Alzheimer’s disease. Cell. 2016;164(4):603–615. doi:10.1016/j.cell.2015.12.05626871627
   PubMed Web of Science ®Google Scholar